Back to the future: improving the use of guidelines-recommended coronary disease secondary prevention at the dawn of the precision medicine era

Affiliations

¹ From Division of Cardiology, Department of Medicine (J.A.R., L.K.N.) and Duke Clinical Research Institute (L.K.N.), Duke University Medical Center, Durham, NC.
² From Division of Cardiology, Department of Medicine (J.A.R., L.K.N.) and Duke Clinical Research Institute (L.K.N.), Duke University Medical Center, Durham, NC. kristin.newby@duke.edu.

Editorial

Jennifer A Rymer et al. Circulation. 2015.

. 2015 Apr 7;131(14):1234-5.

doi: 10.1161/CIRCULATIONAHA.115.015707. Epub 2015 Feb 24.

¹ From Division of Cardiology, Department of Medicine (J.A.R., L.K.N.) and Duke Clinical Research Institute (L.K.N.), Duke University Medical Center, Durham, NC.
² From Division of Cardiology, Department of Medicine (J.A.R., L.K.N.) and Duke Clinical Research Institute (L.K.N.), Duke University Medical Center, Durham, NC. kristin.newby@duke.edu.

No abstract available

Keywords: Editorials; coronary artery disease; guideline adherence; secondary prevention.

Comment on

Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW. Iqbal J, et al. Circulation. 2015 Apr 7;131(14):1269-77. doi: 10.1161/CIRCULATIONAHA.114.013042. Epub 2015 Feb 24. Circulation. 2015. PMID: 25847979 Clinical Trial.